Glaukos (GKOS) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.47
- Estimate
- -$0.09
- Surprise
- +618.7%
- Revenue (period 2026-09-30)
- $211.0M
- Score at report (before → after)
- 5.7 → 6.0/10
Revenue source: xbrl.
How the report landed
Glaukos (GKOS) beat the -$0.09 estimate with adjusted EPS of $0.47 — a large 618.7% upside surprise. TrendMatrix's engine moved from Buy (Wait) (5.7/10) to Hold at 6.0/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates GKOS Hold at 5.9/10.
3 of the last 4 quarters beat the estimate; this quarter's +618.7% surprise compares with a +161.2% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (3/4)
What argues against it
- Concentration risk — Geographic: U.S. customers (74.0%)
- Concentration risk — Product: iStent family and iDose TR glaucoma franchise (83.0%)
- Analyst target reached - limited upside remaining
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $181.43
- Stop
- $168.73
Risk check: RSI 81 — a level conventionally read as overbought; gains at these levels often lean on momentum; trading volume is running 1.7× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-10-29 — shown for context, not personalized investment advice.
GKOS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $10.70B
- P/E (fwd)
- 347.0
- 52-week range
- $76.88–$191.62
- Off 52-week high
- 5.3%
- RSI (14)
- 81
- Volume vs avg
- 1.74×
- Score today
- 5.9/10